NCT07508683

Brief Summary

Subarachnoid hemorrhage (SAH) represents a significant proportion of hemorrhagic strokes. Severe SAH in elderly patients is associated with poorer outcomes compared to younger cohorts. Better characterization of both short- and long -term prognosis in these patients is necessary to facilitate medical decision-making in the intensive care unit (ICU) Primary Objective: The primary objective is to identify prognostic factors associated with poor functional outcome or death at 6 months (± 2 months) in elderly patients admitted to the ICU for SAH. Secondary Objectives: To evaluate in-hospital mortality among elderly patients admitted to the ICU for SAH. To describe the causes of in-hospital death (brain death, withholding/withdrawal of life-sustaining treatment \[WOLST\], other medico-surgical causes) in elderly patients admitted to the ICU for SAH. To describe the care trajectory following hospital discharge for elderly patients admitted to the ICU for SAH. To evaluate the mean length of stay in the ICU and in the hospital (acute care) for elderly patients admitted to the ICU for SAH. To identify prognostic factors associated with poor functional outcome or death at 1 year in elderly patients admitted to the ICU for SAH.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started May 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
May 2026Mar 2027

First Submitted

Initial submission to the registry

March 16, 2026

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
29 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

6 months

First QC Date

March 16, 2026

Last Update Submit

March 31, 2026

Conditions

Keywords

Subarachnoid HemorrhageElderlyPrognostic FactorsIntensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Modified Rankin Scale (MRS) et 6 months

    MRS : scale from 1(no symptoms) to 6 (dead) Good outcome : 0 - 2 Bad outcome: 3 - 6 The MRS grade is either collected if already available in the medical file or estimated retrospectively based on the patient neurological evaluation.

    6 months after ICU discharge

Secondary Outcomes (4)

  • Intrahospital mortality

    Day 28

  • Cause of intrahospital death

    Day 28

  • Destination upon hospital discharge

    Day 28

  • Modified Rankin Scale upon discharge from hospital.

    Day 28

Study Arms (1)

Elderly aneurysmal SAH patients hospitalized in ICU

Patients hospitalized in ICU for aneurysmal subarachnoid hemorrhage between Juin 30, 2021 and Juin 30, 2025. Aged 70 years or over the day of admission in ICU. In accordance with French regulations , the study included patients who did not object to the use of their clinical data after receiving written information.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult patients admitted in ICU for aneurysmal subarachnoid hemorrhage in 4 University Hospital Centers in France (CHU Nancy, CHU Reims, HC de Lyon, CHU Lille) between Juin 30, 2021 et Juin 30, 2025

You may qualify if:

  • Patients hospitalized in ICU for aneurysmal subarachnoid hemorrhage
  • Aged 70 years or over the day of admission in ICU
  • Between Juin 30, 2021 and Juin 30, 2025

You may not qualify if:

  • Decline to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chru Nancy

Nancy, 54000, France

Location

MeSH Terms

Conditions

Subarachnoid Hemorrhage

Condition Hierarchy (Ancestors)

Intracranial HemorrhagesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Viviane MARTIN, Chief of Research Departement

    CHRU NANCY, DRCI

    STUDY CHAIR
  • Elodie JEANBERT, Methodologist, Statistician

    CHRU NANCY, DRCI

    STUDY CHAIR

Central Study Contacts

Ionel M ALB, MD Intensive Care/Anesthesia

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator - MD Intensivist

Study Record Dates

First Submitted

March 16, 2026

First Posted

April 2, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations